缩写名/全名 |
CL LYMPH MYELOM LEUK
Clinical Lymphoma Myeloma & Leukemia |
||||||||||||
ISSN号 | 2152-2650 | ||||||||||||
研究方向 | ONCOLOGY-HEMATOLOGY | ||||||||||||
影响因子 | 2015:2.316, 2016:2.494, 2017:2.308, 2018:2.274, 2019:2.298, | ||||||||||||
出版国家 | UNITED STATES | ||||||||||||
出版周期 | Bimonthly | ||||||||||||
年文章数 | 184 | ||||||||||||
出版年份 | 2010 | ||||||||||||
是否OA | No | ||||||||||||
审稿周期(仅供参考) | 较慢,6-12周 |
||||||||||||
录用比例 | 较易 | ||||||||||||
投稿链接 | http://ees.elsevier.com/clml/ | ||||||||||||
投稿官网 | http://www.journals.elsevier.com/clinical-lymphoma-myeloma-and-leukemia | ||||||||||||
h-index | |||||||||||||
CiteScore | |||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2152-2650%5BISSN%5D | ||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Correlation of microRNA 17-92 cluster host gene (MIR17HG) polymorphisms with susceptibility and prognosis for multiple myemola Author: Hongbo Wu, Ting Huang, Zhifeng Ye, Xiaoqing Fu, Keke Hu, Xuefei Yang Journal: Clinical Lymphoma Myeloma & Leukemia, 2019, Vol., , DOI:10.1016/j.clml.2019.03.018 DOI |
2. | Study on the prognostic value of aberrant antigen in patients with acute B lymphocytic leukemia Author: Jun Liu, Xu Tan, Ying-Ying Ma, Yao Liu, Li Gao, Lei Gao, PeiYang Kong, Xian-Gui Peng, Xi Zhang, Cheng Zhang Journal: Clinical Lymphoma Myeloma & Leukemia, 2019, Vol., , DOI:10.1016/j.clml.2019.03.012 DOI |
3. | Role of p15(INK4B) methylation in patients with myelodysplastic syndromes: a systematic meta-analysis Author: Fang Ye, Ningning Li Journal: Clinical Lymphoma Myeloma & Leukemia, 2019, Vol., , DOI:10.1016/j.clml.2019.03.013 DOI |
4. | Prognostic Value of 1q21 Gain in Multiple Myeloma Author: Dangui Chen, Di Zhou, Jingyan Xu, Rongfu Zhou, Jian Ouyang, Bing Chen Journal: Clinical Lymphoma Myeloma & Leukemia, 2018, Vol., , DOI:10.1016/j.clml.2018.12.002 DOI |
5. | Prophylactic Use of Entecavir for Lymphoma Patients With Past Hepatitis B Virus Infection: A Randomized Controlled Trial Author: Wei Ping Liu, Xiu Bin Xiao, Mei Xue, Gui Qiang Wang, Xiao Pei Wang, Yu Qin Song, Jun Zhu Journal: Clinical Lymphoma Myeloma & Leukemia, 2018, Vol., , DOI:10.1016/j.clml.2018.11.008 DOI |
6. | Progressive Elevation of NT-ProBNP During Chemotherapy Is Related to Asymptomatic Cardiovascular Events in Patients With Multiple Myeloma Author: Yutong Wang, Li Bao, Bin Chu, Shan Gao, Minqiu Lu, Lei Shi, Lina Fu, Lijuan Fang, Qiuqing Xiang Journal: Clinical Lymphoma Myeloma & Leukemia, 2018, Vol., , DOI:10.1016/j.clml.2018.11.011 DOI |
7. | The Role of FLT3-ITD Mutation on de Novo MDS in Chinese Population Author: Fei Xu, Rong Han, Jian Zhang, Zheng Li, Jun Wang, Xiao-Ling Chu, Jing-Qiu Yu, Chao Wang, Tao Tao, Hong-Jie Shen, Su-Ning Chen, De-Pei Wu, Song-Bai Liu, Qiao-Cheng Qiu, Sheng-Li Xue Journal: Clinical Lymphoma Myeloma & Leukemia, 2018, Vol., , DOI:10.1016/j.clml.2018.11.006 DOI |
8. | Clinical Characteristics and Treatment Outcome of Chinese Patients With Systemic Amyloid Light-Chain Amyloidosis: A Retrospective Single-Center Analysis. Author: Zhao Q, Li F, Song P, Zhou X, Wang L, Yu Y, An Z, Wang X, Zhai Y. Journal: Clin Lymphoma Myeloma Leuk. 2016 Feb;16(2):104-10. doi: 10.1016/j.clml.2015.11.001. Epub 2015 Nov 21. PubMed |
9. | Comparative Effectiveness of Newer Tyrosine Kinase Inhibitors Versus Imatinib in the First-Line Treatment of Chronic-Phase Chronic Myeloid Leukemia Across Risk Groups: A Systematic Review and Meta-Analysis of Eight Randomized Trials. Author: Yun S, Vincelette ND, Segar JM, Dong Y, Shen Y, Kim DW, Abraham I. Journal: Clin Lymphoma Myeloma Leuk. 2016 Jun;16(6):e85-94. doi: 10.1016/j.clml.2016.03.003. Epub 2016 Mar 30. PubMed |
10. | Incidence of Second Malignancies of Chronic Myeloid Leukemia During Treatment With Tyrosine Kinase Inhibitors. Author: Yin XF, Wang JH, Li X, Yu MX, Ma ZX, Jin J. Journal: Clin Lymphoma Myeloma Leuk. 2016 Jun 8. pii: S2152-2650(16)30115-X. doi: 10.1016/j.clml.2016.06.010. [Epub ahead of print] PubMed |
|
|